27754271|t|SY 17-1 DYNAMIC REGULATION OF REDOX REGULATING FACTOR APE1 / REF-1 ON THE OXIDATIVE STRESS AND VASCULAR INFLAMMATION
27754271|a|Apurinic/apyrimidinic endonuclease 1 / redox factor-1 (APE1 / Ref-1) is a multifunctional protein that plays a central role in the cellular response to DNA damage and redox regulation against oxidative stress. APE1 / Ref-1 is essential for cellular survival and embryonic lethal in knockout mouse models. Heterozygous APE1 / Ref-1 mice showed impaired endothelium -dependent vasorelaxation, reduced vascular NO levels, and are hypertensive. APE1 / Ref-1 reduces intracellular reactive oxygen species production by negatively regulating the activity of the NADPH oxidase. APE1 / Ref-1 is predominantly localized in the nucleus; however, its subcellular localization is dynamically regulated. Recently, it was shown that APE1 / Ref-1 is secreted in response to hyperacetylation at specific lysine residues. We investigated the functions of extracellular APE1 / Ref-1 with respect to leading anti-inflammatory signaling in TNF-α -stimulated endothelial cells in response to acetylation. Trichostatin A (TSA), an inhibitor of histone deacetylase, considerably suppressed vascular cell adhesion molecule-1 (VCAM-1) in TNF-α -stimulated endothelial cells. During TSA -mediated acetylation in culture, a time - dependent increase in secreted APE1 / Ref-1 was confirmed. Recombinant human APE1 / Ref-1 with reducing activity induced a conformational change in TNFR1 by thiol-disulfide exchange. Following treatment with the neutralizing anti- APE1 / Ref-1 antibody, inflammatory signals via the binding of TNF-α to TNFR1 were remarkably recovered. Furthermore, rh APE1 / Ref-1 inhibited IL-1β - induced VCAM-1 expression in endothelial cells, and it inhibited iNOS or COX-2 expression in lipopolysaccharide -stimulated RAW 264.7 macrophage cells. These results strongly indicate that anti-inflammatory effects of secreted APE1 / Ref-1 and its property of secreted APE1 / Ref-1 may be useful as a therapeutic biomolecule in cardiovascular disease.
27754271	16	26	REGULATION	T043	C1157519
27754271	30	35	REDOX	T044	C0030012
27754271	36	58	REGULATING FACTOR APE1	T116,T126	C1451271
27754271	61	66	REF-1	T116,T126	C1451271
27754271	74	90	OXIDATIVE STRESS	T049	C0242606
27754271	95	116	VASCULAR INFLAMMATION	T047	C0947751
27754271	117	153	Apurinic/apyrimidinic endonuclease 1	T116,T126	C1451271
27754271	156	170	redox factor-1	T116,T126	C1451271
27754271	172	176	APE1	T116,T126	C1451271
27754271	179	184	Ref-1	T116,T126	C1451271
27754271	191	214	multifunctional protein	T116,T123	C0033684
27754271	248	279	cellular response to DNA damage	T043	C1155291
27754271	284	300	redox regulation	T043	C1655231
27754271	309	325	oxidative stress	T049	C0242606
27754271	327	331	APE1	T116,T126	C1451271
27754271	334	339	Ref-1	T116,T126	C1451271
27754271	357	374	cellular survival	T043	C0007620
27754271	379	395	embryonic lethal	T046	C0752350
27754271	399	413	knockout mouse	T015	C0206745
27754271	414	420	models	T008	C0887965
27754271	422	434	Heterozygous	T032	C0019425
27754271	435	439	APE1	T116,T126	C1451271
27754271	442	452	Ref-1 mice	T116,T126	C1451271
27754271	460	468	impaired	T037	C0010957
27754271	469	480	endothelium	T024	C0014257
27754271	492	506	vasorelaxation	T042	C0042401
27754271	508	515	reduced	T080	C0392756
27754271	516	524	vascular	T023	C0005847
27754271	525	534	NO levels	T059	C3810607
27754271	544	556	hypertensive	T033	C0857121
27754271	558	562	APE1	T116,T126	C1451271
27754271	565	570	Ref-1	T116,T126	C1451271
27754271	579	592	intracellular	T082	C0178719
27754271	593	616	reactive oxygen species	T123,T196	C0162772
27754271	631	686	negatively regulating the activity of the NADPH oxidase	T044	C1151146
27754271	688	692	APE1	T116,T126	C1451271
27754271	695	700	Ref-1	T116,T126	C1451271
27754271	718	727	localized	T082	C0392752
27754271	735	742	nucleus	T026	C0007610
27754271	757	768	subcellular	T026	C0729605
27754271	769	781	localization	T169	C0475264
27754271	785	806	dynamically regulated	T038	C1327622
27754271	836	840	APE1	T116,T126	C1451271
27754271	843	848	Ref-1	T116,T126	C1451271
27754271	852	860	secreted	T043	C1327616
27754271	864	892	response to hyperacetylation	T044	C1521754
27754271	905	920	lysine residues	T116,T121,T123	C0024337
27754271	942	951	functions	T044	C1527118
27754271	955	968	extracellular	T026	C0521119
27754271	969	973	APE1	T116,T126	C1451271
27754271	976	981	Ref-1	T116,T126	C1451271
27754271	1006	1033	anti-inflammatory signaling	T044	C1148560
27754271	1037	1042	TNF-α	T116,T129	C1456820
27754271	1055	1072	endothelial cells	T025	C0225336
27754271	1076	1084	response	T043	C2612728
27754271	1088	1099	acetylation	T044	C1521754
27754271	1101	1115	Trichostatin A	T109,T195	C0077063
27754271	1117	1120	TSA	T109,T195	C0077063
27754271	1126	1158	inhibitor of histone deacetylase	T116,T121,T126	C1512474
27754271	1173	1183	suppressed	T169	C1260953
27754271	1184	1217	vascular cell adhesion molecule-1	T116,T129	C0078056
27754271	1219	1225	VCAM-1	T116,T129	C0078056
27754271	1230	1235	TNF-α	T116,T129	C1456820
27754271	1248	1265	endothelial cells	T025	C0225336
27754271	1274	1277	TSA	T109,T195	C0077063
27754271	1288	1299	acetylation	T044	C1521754
27754271	1303	1310	culture	T059	C0430400
27754271	1314	1318	time	T079	C0040223
27754271	1321	1330	dependent	T080	C0851827
27754271	1331	1339	increase	T169	C0442805
27754271	1343	1351	secreted	T043	C1327616
27754271	1352	1356	APE1	T116,T126	C1451271
27754271	1359	1364	Ref-1	T116,T126	C1451271
27754271	1369	1378	confirmed	T033	C0750484
27754271	1380	1391	Recombinant	T116	C0034861
27754271	1392	1402	human APE1	T116,T126	C0140145
27754271	1405	1410	Ref-1	T116,T126	C0140145
27754271	1425	1433	activity	T044	C1537044
27754271	1434	1441	induced	T169	C0205263
27754271	1444	1465	conformational change	T044	C0301641
27754271	1469	1474	TNFR1	T116,T192	C0255808
27754271	1478	1502	thiol-disulfide exchange	T044	C1151052
27754271	1514	1523	treatment	T061	C0087111
27754271	1533	1545	neutralizing	T116,T129	C0475463
27754271	1552	1556	APE1	T116,T126	C1451271
27754271	1559	1564	Ref-1	T116,T126	C1451271
27754271	1565	1573	antibody	T116,T129	C0003241
27754271	1575	1595	inflammatory signals	T043	C0037083
27754271	1604	1611	binding	T044	C1167622
27754271	1615	1620	TNF-α	T116,T129	C1456820
27754271	1624	1629	TNFR1	T116,T192	C0255808
27754271	1646	1655	recovered	T080	C0521108
27754271	1670	1672	rh	T116	C0034861
27754271	1673	1677	APE1	T116,T126	C1451271
27754271	1680	1685	Ref-1	T116,T126	C0140145
27754271	1686	1695	inhibited	T052	C3463820
27754271	1696	1701	IL-1β	T116,T129	C0021753
27754271	1704	1711	induced	T169	C0205263
27754271	1712	1718	VCAM-1	T116,T129	C0078056
27754271	1719	1729	expression	T045	C1171362
27754271	1733	1750	endothelial cells	T025	C0225336
27754271	1759	1768	inhibited	T052	C3463820
27754271	1769	1773	iNOS	T116,T126	C1533698
27754271	1777	1782	COX-2	T116,T126	C0387583
27754271	1783	1793	expression	T045	C1171362
27754271	1797	1815	lipopolysaccharide	T109	C0023810
27754271	1828	1854	RAW 264.7 macrophage cells	T025	C4042840
27754271	1893	1918	anti-inflammatory effects	T080	C1515999
27754271	1922	1930	secreted	T043	C1327616
27754271	1931	1935	APE1	T116,T126	C1451271
27754271	1938	1943	Ref-1	T116,T126	C1451271
27754271	1964	1972	secreted	T043	C1327616
27754271	1973	1977	APE1	T116,T126	C1451271
27754271	1980	1985	Ref-1	T116,T126	C1451271
27754271	2005	2028	therapeutic biomolecule	T073	C0304231
27754271	2032	2054	cardiovascular disease	T047	C0007222